NEW JOURNEY HEALTH TECHNOLOGY GROUP CO.,LTD New Journey Health Technology Group Co.,LTD Stock
Equities
002219
CNE1000009R5
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.41 CNY | +3.43% |
|
+8.07% | -20.46% |
| Sales 2022 | 3.15B 435M | Sales 2023 | 3.59B 496M | Capitalization | 10.33B 1.43B |
|---|---|---|---|---|---|
| Net income 2022 | 156M 21.53M | Net income 2023 | 30M 4.14M | EV / Sales 2022 | 4.31 x |
| Net Debt 2022 | 728M 100M | Net Debt 2023 | 1.43B 197M | EV / Sales 2023 | 3.28 x |
| P/E ratio 2022 |
82.6
x | P/E ratio 2023 |
333
x | Employees | 7,803 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 47.15% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.30% | ||
| 1 week | +4.48% | ||
| Current month | -6.80% | ||
| 1 month | -8.27% | ||
| 3 months | -13.70% | ||
| 6 months | -25.80% | ||
| Current year | -23.10% |
1 week
2.21
2.36
1 month
2.192.55
Current year
1.973.04
1 year
1.975.25
3 years
1.975.88
5 years
0.965.88
10 years
0.9619.01
| Managers | Title | Age | Since |
|---|---|---|---|
Jun Liu
DFI | Director of Finance/CFO | 45 | 21-03-28 |
Li Hua Song
BRD | Director/Board Member | 61 | 18-12-23 |
Ni Xiang
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Si Hong Luo
BRD | Director/Board Member | 59 | 22-09-12 |
Jun Pu
BRD | Director/Board Member | 47 | 21-03-28 |
Li Hua Song
BRD | Director/Board Member | 61 | 18-12-23 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.22% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-25 | 2.41 | +3.43% | 26 990 000 |
| 24-04-25 | 2.33 | +1.30% | 19,265,500 |
| 24-04-24 | 2.3 | 0.00% | 17,704,300 |
| 24-04-23 | 2.3 | +1.32% | 22,171,210 |
| 24-04-22 | 2.27 | +1.34% | 24,009,450 |
End-of-day quote Shenzhen S.E., April 24, 2024
More quotes
New Journey Health Technology Group Co Ltd, formerly Hengkang Medical Group Co Ltd, is a China-based company mainly engaged in the provision of medical services. The Company is mainly engaged in two businesses. The medical service business mainly provides medical services in general hospitals and specialized hospitals. The pharmaceutical manufacturing business is mainly engaged in the research and development, production and sales of pharmaceuticals. The Company mainly conducts its businesses in the domestic market.
Calendar
2024-04-25
- Q1 2024 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| -23.10% | 1.1B | |
| -14.73% | 84.87B | |
| +16.05% | 83.08B | |
| +10.92% | 29.4B | |
| -12.73% | 16.72B | |
| -3.24% | 16.4B | |
| -1.78% | 15.04B | |
| -0.40% | 11.88B | |
| -31.75% | 11.86B | |
| -4.88% | 11.88B |
- Stock Market
- Equities
- 002219 Stock
